Also, the tumour-promoting function of miR-182 overexpression was reversed with combined transfection of miR-182 mimics and IκBα dominant-negative mutant construct, indicating that miR-182 promotes GBM tumour through the NF-κB pathway [78]. The gene discussed is NFKB1; the disease is glioblastoma.